N-acetylgalactosaminuronic acid

IGAN1 ; Homo sapiens







18 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30553446 Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients. 2019 Jan 22 4
2 30570353 Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1. 2018 Dec 4
3 25281698 N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy. 2015 Feb 1
4 24131475 N-acetylgalactosamine exposure of serum IgA1 was associated with glomerulosclerosis and tubular atrophy/interstitial fibrosis of IgA nephropathy patients. 2014 Jan 2
5 24918438 Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy. 2014 4
6 23398317 Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy. 2013 Sep 2
7 23098908 Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy. 2012 Nov 23 2
8 17495450 IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1. 2007 1
9 18046671 Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy. 2007 Nov-Dec 1
10 17050773 Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. 2006 Dec 1
11 15954905 Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. 2005 Jul 2
12 15086888 Aberrant glycosylation in IgA nephropathy (IgAN). 2004 May 1
13 11518779 Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. 2001 Sep 2
14 10777713 Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. 2000 Apr 29 1
15 11115067 Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA. 2000 Dec 1
16 10393701 Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. 1999 Jul 1
17 10446944 Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. 1999 Aug 2
18 9555659 Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. 1998 Apr 1